https://archive.is/i92zL

Europe’s last manufacturer of ingredients for some vital antibiotics is closing its biggest domestic factory and shifting some production to China

Lossmaking Xellia Pharmaceuticals said it could only survive against Chinese competition by moving many of its products to its plant there.

About 80 per of APIs used in the EU already come from China.